Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prestige Consumer Healthcare (PBH) Other Non-Current Liabilities: 2013-2025

Historic Other Non-Current Liabilities for Prestige Consumer Healthcare (PBH) over the last 12 years, with Sep 2025 value amounting to $5.4 million.

  • Prestige Consumer Healthcare's Other Non-Current Liabilities rose 4.98% to $5.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.4 million, marking a year-over-year increase of 4.98%. This contributed to the annual value of $5.4 million for FY2025, which is 41.31% down from last year.
  • Prestige Consumer Healthcare's Other Non-Current Liabilities amounted to $5.4 million in Q3 2025, which was down 0.50% from $5.4 million recorded in Q2 2025.
  • In the past 5 years, Prestige Consumer Healthcare's Other Non-Current Liabilities registered a high of $9.2 million during Q1 2024, and its lowest value of $5.0 million during Q4 2024.
  • Its 3-year average for Other Non-Current Liabilities is $6.8 million, with a median of $5.4 million in 2025.
  • Per our database at Business Quant, Prestige Consumer Healthcare's Other Non-Current Liabilities crashed by 66.15% in 2021 and then climbed by 12.49% in 2024.
  • Over the past 5 years, Prestige Consumer Healthcare's Other Non-Current Liabilities (Quarterly) stood at $8.4 million in 2021, then rose by 5.21% to $8.9 million in 2022, then rose by 0.53% to $8.9 million in 2023, then crashed by 43.61% to $5.0 million in 2024, then rose by 4.98% to $5.4 million in 2025.
  • Its last three reported values are $5.4 million in Q3 2025, $5.4 million for Q2 2025, and $5.4 million during Q1 2025.